⌘K

Login Start Free

Home/Filings/4/0001213900-19-004003

4//SEC Filing

Truluck Joseph 4

Accession 0001213900-19-004003

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 6:46 PM ET

Size

5.4 KB

Accession

0001213900-19-004003

Insider Transaction Report

Form 4

Period: 2019-03-10

ADIAL PHARMACEUTICALS, INC.ADIL

Chief Financial Officer

Transactions

Award
Stock Option
2019-03-10+180,000→ 180,000 total
Exercise: $3.39From: 2019-04-10Exp: 2029-03-09→ Common Stock (180,000 underlying)

Footnotes (1)

[F1]These options vest pro rata on a monthly basis over 36 months.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001718091

Filing Metadata

Form type: 4
Filed: Mar 11, 8:00 PM ET
Accepted: Mar 12, 6:46 PM ET
Size: 5.4 KB

View on SEC.gov